Melanoma microRNA signature predicts post-recurrence survival

PURPOSE: To identify a melanoma miRNA expression signature that is predictive of outcome and then evaluate its potential to improve risk stratification when added to the standard of care staging criteria. EXPERIMENTAL DESIGN: Total RNA was extracted from 59 formalin-fixed paraffin embedded (FFPE) me...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cancer Res
Päätekijät: Segura, Miguel F., Belitskaya-Lévy, Ilana, Rose, Amy E., Zakrzewski, Jan, Gaziel, Avital, Hanniford, Douglas, Darvishian, Farbod, Berman, Russell, Shapiro, Richard, Pavlick, Anna, Osman, Iman, Hernando, Eva
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662869/
https://ncbi.nlm.nih.gov/pubmed/20179230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-2721
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia